Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GPhA Makes Spreadsheet Case For Patent Settlements After Legal Loss

Executive Summary

IMS report finds that 33 drugs launched prior to patent expiry as a result of patent settlements reduced drug costs by $25.5 billion from 2005 to 2012. But the selection of which settlements to calculate the savings from reveals the fundamental difference in perspectives between industry and FTC that remain in the wake of the Supreme Court ruling.

Advertisement

Related Content

FDA May Drop Generic Liability Shield, Allow ANDA Manufacturers To Change Labels

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS055479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel